As demonstrated in our study, evaluating 19 autoantibodies’ EIA with the ANA staining pattern increases the usefulness of further investigation using ANA profile dot enzyme immunoassay in the absence of ANA-IIF positivity if the clinical characteristics in a given clinical context are highly suggestive of SLE. This evidence concerns the gene BTG3 and systemic lupus erythematosus.